PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies 5th January 2022
PhoreMost and XtalPi sign AI-based pharmaceutical drug discovery collaboration agreement 8th September 2020
Drug Discovery World feature article: ‘Target discovery and drug development – what comes after CRISPR?’ 30th April 2020